We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: oropharyngeal cancer
MedXY News
EnglishTag

oropharyngeal cancer

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Insights from the RTOG 1016 Study
newsoropharyngeal cancerRTOG 1016

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Insights from the RTOG 1016 Study

By MedXY|Aug 31, 2026

This analysis of RTOG 1016 validates the prognostic value of imaging-detected extranodal extension (iENE) in p16-positive oropharyngeal cancer, supporting its integration into the AJCC/UICC TNM9 staging system and its implications for patie

Swallowing Function and Perioperative Complications After Transoral Robotic Surgery: A Comprehensive Review
Clinical Updatesoropharyngeal cancerperioperative complications

Swallowing Function and Perioperative Complications After Transoral Robotic Surgery: A Comprehensive Review

By MedXY|Jun 29, 2026

This review synthesizes evidence on swallowing function and perioperative complications following transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC), highlighting excellent short-term swallowing outcomes and

newshead and neck cancerhypoglossal neuropathy

MDASI-HN Symptom Profiling for Early Risk Stratification of Hypoglossal Neuropathy in Oropharyngeal Cancer Survivors

By MedXY|Jun 18, 2026

This study found that patient-reported speech/voice and related head-and-neck symptoms can help predict hypoglossal neuropathy risk after oropharyngeal cancer treatment, supporting earlier surveillance with the MDASI-HN-NERVE score.

Impact of Immunocompromise on Survival in HPV-Positive Throat Cancer Patients
newsHPVoropharyngeal cancer

Impact of Immunocompromise on Survival in HPV-Positive Throat Cancer Patients

By MedXY|May 8, 2026

This study examines how pre-existing immunocompromise affects survival and outcomes in patients with HPV-positive oropharyngeal cancer treated surgically. Immunocompromised patients showed significantly worse overall survival compared to no

AI-Driven Detection of Extranodal Extension Outperforms Radiologists in Predicting Outcomes for HPV-Positive Oropharyngeal Cancer
AIartificial intelligenceExtranodal Extension

AI-Driven Detection of Extranodal Extension Outperforms Radiologists in Predicting Outcomes for HPV-Positive Oropharyngeal Cancer

By MedXY|Feb 11, 2026

A single-center study demonstrates that an AI pipeline for CT-based lymph node segmentation and extranodal extension classification significantly improves prognostic accuracy for HPV-positive oropharyngeal cancer compared to traditional rad

Proton Therapy Outperforms Photons in Oropharyngeal Cancer: Superior Survival and Reduced Toxicity in a Phase 3 Trial
newsclinical trialoropharyngeal cancer

Proton Therapy Outperforms Photons in Oropharyngeal Cancer: Superior Survival and Reduced Toxicity in a Phase 3 Trial

By MedXY|Jan 14, 2026

A landmark Phase 3 trial establishes Intensity-Modulated Proton Therapy (IMPT) as a new standard for oropharyngeal cancer, demonstrating non-inferior progression-free survival, significantly improved overall survival, and a marked reduction

FDG-PET-Guided Dose De-escalation: A New Standard for HPV-Positive Oropharyngeal Cancer?
newsFDG-PEToncology

FDG-PET-Guided Dose De-escalation: A New Standard for HPV-Positive Oropharyngeal Cancer?

By MedXY|Jan 11, 2026

A multi-center phase II trial demonstrates that mid-treatment FDG-PET imaging can safely identify patients with HPV+ oropharyngeal cancer for radiation dose reduction, resulting in non-inferior tumor control and significantly improved quali

HPV-Positive Oropharyngeal Cancer Retains a Strong Survival Advantage After Surgery in Patients Aged ≥70
newselderlyHPV

HPV-Positive Oropharyngeal Cancer Retains a Strong Survival Advantage After Surgery in Patients Aged ≥70

By MedXY|Nov 21, 2025

In a multi-center cohort of 345 surgically treated patients aged 70 or older with tonsil or base‑of‑tongue SCC, p16 positivity was associated with substantially better 5‑year overall and disease‑free survival compared with p16‑negative tumo

Unilateral TORS for HPV-Positive Tonsillar Cancer Appears Safe — Bilateral Contralateral Tonsillectomy May Add Harm Without Clear Benefit
newsHPVoropharyngeal cancer

Unilateral TORS for HPV-Positive Tonsillar Cancer Appears Safe — Bilateral Contralateral Tonsillectomy May Add Harm Without Clear Benefit

By MedXY|Nov 21, 2025

In a retrospective cohort of 158 HPV-positive tonsil SCC patients, omission of prophylactic contralateral tonsillectomy during TORS was not associated with worse survival and showed trends toward fewer hemorrhages, ED visits, and shorter ho

Epstein-Barr Virus Serology as a Predictor of Persistent Oral HPV Infection in Men: Insights From the Finnish Family HPV Study
Infectious DiseasesEBVEpstein-Barr virus

Epstein-Barr Virus Serology as a Predictor of Persistent Oral HPV Infection in Men: Insights From the Finnish Family HPV Study

By MedXY|Oct 27, 2025

A Finnish longitudinal study reveals that elevated Epstein-Barr virus antibody levels are significantly associated with persistent oral HPV infections, highlighting potential viral interplay in oropharyngeal oncogenesis risk.

Artificial Intelligence in Imaging-Based Extranodal Extension Detection: Advancing Prognostication in HPV-Positive Oropharyngeal Cancer
AIartificial intelligenceExtranodal Extension

Artificial Intelligence in Imaging-Based Extranodal Extension Detection: Advancing Prognostication in HPV-Positive Oropharyngeal Cancer

By MedXY|Oct 22, 2025

An AI-driven model accurately detects imaging-based extranodal extension in HPV-positive oropharyngeal cancer from CT scans, improving outcome prediction beyond expert radiologist assessments and identifying patients at higher risk of poore

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men
Medical Newscervical cancerHPV

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men

By MedXY|Oct 7, 2025

HPV-related oropharyngeal cancer incidence has surpassed cervical cancer, with men facing a 5-10 fold higher risk. Understanding this shift, symptoms, risks, and the critical role of HPV vaccination can transform prevention and early detect

Long-Term Outcomes of Transoral Surgery with Risk-Adapted Adjuvant Therapy in HPV-Positive Oropharyngeal Cancer: Results from the E3311 Trial
Clinical UpdatesHPVoropharyngeal cancer

Long-Term Outcomes of Transoral Surgery with Risk-Adapted Adjuvant Therapy in HPV-Positive Oropharyngeal Cancer: Results from the E3311 Trial

By MedXY|Oct 1, 2025

The E3311 phase II trial shows excellent long-term survival with deintensified postoperative management after transoral surgery in HPV-associated oropharyngeal cancer, with most patients spared from high-dose radiation and chemotherapy.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story